A better treatment not available in the USA, but approved in Russia and has already helped 10,000 people with chemo called "Novo Two"
N0V-002 (novo-two) is a New adjunct medication used with standard chemotherapy testing for FDA approval in the USA.
Increased the ability of patients to tolerate Chemo to the full 100%
Increased the Cancer Survival rate by 80%
They are accepting some patients under FDA Fast Track SPA Phase III in the USA.
See "$150,000 Grant" message on this board:
http://messages.finance.yahoo.com/mb/NVLT
Novelos' pipeline of drugs is based on oxidized glutathione, a natural metabolite that is part of the glutathione pathway. This pathway is the primary determinant of intracellular redox (oxidation/reduction) potential and, as such, plays a key role in cell protection (e.g. detoxification) and in regulation of cell signaling pathways (e.g. leading to cytokine production). Novelos’ lead products are believed to act, in part, via post-translational modification (glutathionylation) of critical regulatory proteins that mediate processes including immune function, cell proliferation and tumor progression (in combination with chemotherapy). They may also sensitize tumor cells to certain chemotherapeutic drugs by modifying drug detoxification processes.
2007-10-20 05:14:38
·
answer #1
·
answered by Bixbyte 4
·
0⤊
0⤋
I don't know what your question about pancreatic cancer is, but my dad passed away from this disease 6 months after being diagnosed. Peace.
2007-10-19 22:38:31
·
answer #2
·
answered by Corona 5
·
2⤊
0⤋